
Onabotulinum Toxin A (Botox) for Spasticity in Patients With Acquired Brain Injury
Author(s) -
Yan Li,
Aleksandra Grobelna
Publication year - 2021
Publication title -
canadian journal of health technologies
Language(s) - English
Resource type - Journals
ISSN - 2563-6596
DOI - 10.51731/cjht.2021.61
Subject(s) - spasticity , traumatic brain injury , medicine , guideline , botulinum toxin , physical medicine and rehabilitation , anesthesia , psychiatry , pathology
No relevant literature was identified regarding the clinical effectiveness or cost-effectiveness of onabotulinum toxin A (Botox) for reducing spasticity in patients with traumatic or non-traumatic–acquired brain injury.
Authors of 1 evidence-based guideline recommend the use of botulinum toxin (subtype and formulation not specified) for the treatment of spasticity associated with traumatic brain injury.